Open Your Free Demat Account
Enjoy low brokerage on delivery trades
Nephrocare Health has opened its IPO for subscription, with Day 1 reflecting measured and category-specific participation. The issue is a fresh public offering and includes allocations for QIBs, NIIs, retail investors, and employees. Activity on the first day was led by retail and employee categories, while QIB bids in the non-anchor segment remained limited.
Below is a detailed look at today’s subscription performance and the structural details of the issue.
To explore the complete offer details, visit the Nephrocare Health IPO page.
As of 4:04:45 PM on December 10, 2025, the Nephrocare Health IPO recorded an overall subscription of 0.11×.
Employee participation stood out at 0.46×, followed by retail investors at 0.19×, while QIB (ex-anchor) demand is yet to pick up traction.
Investor Category | Subscription (times) | Shares Offered* | Shares Bid For | Total Amount (₹ Cr.)* |
Anchor Investors | 1.00 | 56,57,919 | 56,57,919 | 260.264 |
QIB (Ex Anchor) | 0.00 | 37,68,224 | 448 | 0.021 |
Non-Institutional Buyers (NII) | 0.07 | 28,27,843 | 1,96,832 | 9.054 |
— bNII (bids > ₹10L) | 0.04 | 18,85,229 | 80,320 | 3.695 |
— sNII (bids < ₹10L) | 0.12 | 9,42,614 | 1,16,512 | 5.360 |
Retail Investors | 0.19 | 65,98,301 | 12,25,856 | 56.389 |
Employees | 0.46 | 83,532 | 38,592 | 1.775 |
Total (ex-anchor) | 0.11 | 1,32,77,900 | 14,61,728 | 67.239 |
Total Applications Received: 29,241
Note:
*“Shares Offered” and “Total Amount” are calculated at the upper end of the price band.
*The anchor portion is excluded from the total public allocation.
Nephrocare Health IPO is a public issue of 1.89 crore equity shares. The allocation structure covers QIBs, NIIs, retail investors, and employee participants.
Category | Shares Offered | Amount (₹ Cr.) | Size (%) |
QIB | 94,26,143 | 433.60 | 49.78% |
— Anchor Investors | 56,57,919 | 260.26 | 29.88% |
— QIB (Ex Anchor) | 37,68,224 | 173.34 | 19.90% |
NII | 28,27,843 | 130.08 | 14.93% |
Retail | 65,98,301 | 303.52 | 34.85% |
Employee | 83,532 | 3.84 | 0.44% |
Total | 1,89,35,819 | 871.05 | 100% |
As outlined in the issue objectives, Nephrocare Health intends to use the net proceeds toward:
Setting up new dialysis centres and expanding existing healthcare facilities
Investment in medical equipment and clinical infrastructure
Funding working capital requirements
Repayment and prepayment of certain borrowings
General corporate purposes
Nephrocare Health allotted 56,57,919 shares to anchor investors at ₹460 per share.
Parameter | Details |
Anchor investor bid opening date | Dec 09, 2025 |
Anchor investor price | ₹460.00 |
Anchor investors as % of QIBs | null% |
Shares locked-in for 30 days | 0 |
Shares locked-in for 90 days | 0 |
Click here to check out recently closed IPO
Day 1 of the Nephrocare Health IPO reflected a measured start, with stronger participation from employees and retail investors. QIB and NII activity may evolve as the subscription window progresses, giving a clearer picture of overall demand.
Investors can continue tracking day-wise subscription data, allotment timelines, and listing updates for deeper insight.
Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your IPO allotment status for Nephrocare Health IPO.
Disclaimer :
The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes. The securities are quoted as an example and not as a recommendation. Past performance is not necessarily a guide to future performance.
The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.
Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.
BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.
Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For more disclaimer, check here : https://www.bajajbroking.in/disclaimer
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading